# Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction

> **NCT06800274** · PHASE4 · COMPLETED · sponsor: **Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona** · enrollment: 134 (actual)

## Conditions studied

- Allergic Conjunctivitis
- Dry Eye Disease (DED)

## Interventions

- **DRUG:** NAAGA (N-acetyl-aspartyl-glutamate) 49 mg/mL
- **DRUG:** azelastine hydrochloride 0.05%

## Key facts

- **NCT ID:** NCT06800274
- **Lead sponsor:** Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-21
- **Primary completion:** 2024-03-28
- **Final completion:** 2024-03-28
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06800274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06800274, "Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06800274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*